推荐活动

全自动化的艾滋病检测设备或将面世

首页 » 研究 » 检验 2015-02-12 转化医学网 赞(3)
分享: 
导读
Rheonix从美国国立卫生研究院获得了150万美元资助,这将帮助该公司在单一样本中,完成全自动化的自我确认检测的实验,该实验可以同时检测HIV抗体和病毒RNA。

  Rheonix今天宣布,其从美国国立卫生研究院获得了150万美元资助。该资助属于第二期小企业创新研究资助项目,将帮助该公司在单一样本中,完成全自动化的自我确认检测实验,以达到同时检测HIV抗体和病毒RNA。

  去年,Rheonix在圆满完成了第一阶段的概念性证明之后,获得了牙科和颅面国立研究所19万美元的资助。Rheonix说,新的资助将用于实现该检测技术的商业化应用。

  Rheonix试剂装置(CARD)是一个完全自动化的分子检测系统,可以进行样品提取,纯化,扩增和检测所有的商业化测试都将利用Rheonix的化学试剂和试剂装置(CARD)来完成,该公司目前正在针对血液和唾液样本设计相关的试验。

  在与纽约大学的合作中,Rheonix完成了1期研究,并证明了CARD系统能够在一个完全自动化的方式中,同时检测HIV抗体和实际病毒RNA载量。

  “能够提供这样一个全自动化的检测平台,将使世界上资源有限地区能够获得血清学检测和进行HIV的分子水平的确认,”Rheonix的负责科学和临床事务的高级副总裁Richard Montagna在一份申明中这样表示。

原文:

  Rheonix said today that it has received a $1.5 million Phase II Small Business Innovation Research grant from the National Institutes of Health to complete the development of a fully automated self-confirming assay to simultaneously detect HIV/AIDS antibodies and viral RNA in a single specimen.
  The grant, being administered by the National Institute of Dental and Craniofacial Research, follows the successful completion of a Phase I proof-of-concept grant worth $190,000 and awarded last year to Ithaca, NY-based Rheonix. The new funding will be used to achieve a commercial-ready test for use in the developing world, Rheonix said.
  The assay will be performed on Rheonix's Chemistry and Reagent Device (CARD), a fully automated molecular testing system that performs sample extraction, purification, amplification, and detection. The company is designing the test to work with blood and saliva samples.
  In collaboration with New York University, Rheonix completed its Phase I study by demonstrating that the CARD system was able to detect both antibodies against HIV and actual viral RNA in a fully automated manner.

  "Being able to provide such a fully automated testing platform will allow resource-limited regions of world to have their first-ever opportunity to perform simultaneous serological testing and molecular confirmation of HIV," Richard Montagna, senior vice president for scientific and clinical affairs at Rheonix, said in a statement.(转化医学网360zhyx.com)

  以上为转化医学网原创翻译整理。如需转载,请联系 info@360zhyx.com。

评论:
评 论
共有 0 条评论

    还没有人评论,赶快抢个沙发

相关阅读